[1]
|
Mirshafiey, A., Matsuo, H., Nakane, S., Rehm, B.H., Koh, C.S. and Miyoshi, S. (2005) Novel Immunosuppressive Therapy by M2000 in Experimental Multiple Sclerosis. Immunopharmacology and Immunotoxicology, 27, 255-265. http://dx.doi.org/10.1081/IPH-200067751
|
[2]
|
Cudrici, C., Niculescu, T., Niculescu, F., Shin, M.L. and Rus, H. (2006) Oligodendrocyte Cell Death in Pathogenesis of Multiple Sclerosis: Protection of Oligodendrocytes from Apoptosis by Complement. Journal of Rehabilitation Research and Development, 43, 123-132. http://dx.doi.org/10.1682/JRRD.2004.08.0111
|
[3]
|
Korn, T. (2008) Pathophysiology of Multiple Sclerosis. Journal of Neurology, 225, 2-6. http://dx.doi.org/10.1007/s00415-008-6001-2
|
[4]
|
Mc Guire, C., Volckaert, T., Wolke, U., Sze, M., de Rycke, R., Waisman, A., et al. (2010) Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination. Journal of Immunology, 185, 7646-7653. http://dx.doi.org/10.4049/jimmunol.1000930
|
[5]
|
Mirshafiey, A. (2007) Novel Promising Therapeutic Agents in Multiple Sclerosis. Recent Patents on Inflammation and Allergy Drug Discovery, 1, 218-224. http://dx.doi.org/10.2174/187221307782418856
|
[6]
|
Raine, C.S. (1997) The Neuropathology of Multiple Sclerosis. In: Raine, C.S., McFarland, H.F. and Tourtellotte, W.W., Eds., Multiple Sclerosis Clinical and Pathogenetic Basis, Chapman & Hall Medical, London, 151-171.
|
[7]
|
Proskuryakov, S.Y., Konoplyannikov, A.G. and Gabai, V.L. (2003) Necrosis: A Specific Form of Programmed Cell Death? Experimental Cell Research, 283, 1-16. http://dx.doi.org/10.1016/S0014-4827(02)00027-7
|
[8]
|
Elmore, S. (2007) Apoptosis: A Review of Programmed Cell Death. Toxicologic Pathology, 35, 495-516. http://dx.doi.org/10.1080/01926230701320337
|
[9]
|
McEntyre, J.R. and Gibson, T.J. (2004) Patterns and Clusters within the PSM Column in TiBS, 1992-2004. Trends in Biochemical Sciences, 29, 627-633. http://dx.doi.org/10.1016/j.tibs.2004.10.006
|
[10]
|
Valmiki, M.G. and Ramos, J.W. (2009) Death Effector Domain-Containing Proteins. Cellular and Molecular Life Sciences, 66, 814-830. http://dx.doi.org/10.1007/s00018-008-8489-0
|
[11]
|
Kohl, A. and Grütter, M.G. (2004) Fire and Death: The Pyrin Domain Joins the Death-Domain Superfamily. Comptes Rendus Biologies, 327, 1077-1086. http://dx.doi.org/10.1016/j.crvi.2004.08.006
|
[12]
|
Ferrao, R. and Wu, H. (2012) Helical Assembly in the Death Domain (DD) Superfamily. Current Opinion in Structural Biology, 22, 241-247. http://dx.doi.org/10.1016/j.sbi.2012.02.006
|
[13]
|
Reed, J.C., Doctor, K.S. and Godzik, A. (2004) The Domains of Apoptosis: A Genomics Perspective. Science’s Signal Transduction Knowledge Environment, 2004, re9.
|
[14]
|
Lahm, A., Paradisi, A., Green, D.R. and Melino, G. (2003) Death Fold Domain Interaction in Apoptosis. Cell Death and Differentiation, 10, 10-12. http://dx.doi.org/10.1038/sj.cdd.4401203
|
[15]
|
Huang, B., Eberstadt, M., Olejniczak, E.T., Meadows, R.P. and Fesik, S.W. (1996) NMR Structure and Mutagenesis of the Fas (APO-1/CD95) Death Domain. Nature, 384, 638-641. http://dx.doi.org/10.1038/384638a0
|
[16]
|
Park, H.H., Lo, Y., Lin, S., Wang, L., Yang, J.K. and Wu, H. (2007) The Death Domain Superfamily in Intracellular Signaling of Apoptosis and Inflammation. Annual Review of Immunology, 25, 561-586. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141656
|
[17]
|
Park, H.H. and Wu, H. (2006) Crystal Structure of RAIDD Death Domain Implicates Potential Mechanism of PIDDosome Assembly. Journal of Molecular Biology, 357, 358-364. http://dx.doi.org/10.1016/j.jmb.2005.12.082
|
[18]
|
Xiao, T., Towb, P., Wasserman, S.A and Sprang, S.R. (1999) Three-Dimensional Structure of a Complex between the Death Domains of Pelle and Tube. Cell, 99, 545-555. http://dx.doi.org/10.1016/S0092-8674(00)81542-1
|
[19]
|
Lin, S.C., Lo, Y.C. and Wu, H. (2010) Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling. Nature, 465, 885-890. http://dx.doi.org/10.1038/nature09121
|
[20]
|
Eberstadt, M., Huang, B., Chen, Z., Meadows, R.P., Ng, S-C., Zheng, L., et al. (1998) NMR Structure and Mutagenesis of the FADD (Mort1) Death-Effector Domain. Nature, 392, 941-945. http://dx.doi.org/10.1038/31972
|
[21]
|
Hill, J.M., Vaidyanathan, H., Ramos, J.W., Ginsberg, M.H. and Werner, M.H. (2002) Recognition of ERK MAP Kinase by PEA-15 Reveals a Common Docking Site within the Death Domain and the Death Effector Domain. The EMBO Journal, 21, 6494-6504. http://dx.doi.org/10.1093/emboj/cdf641
|
[22]
|
Yang, J.K., Wang, L., Zheng, L., Wan, F., Ahmed, M., Lenardo, M.J. and Wu, H. (2005) Crystal Structure of MC159 Reveals Molecular Mechanism of DISC Assembly and FLIP Inhibition. Molecular Cell, 20, 939-949. http://dx.doi.org/10.1016/j.molcel.2005.10.023
|
[23]
|
Li, F.Y., Jeffrey, P.D., Yu, J.W. and Shi, Y. (2006) Crystal Structure of a Viral FLIP: Insights into FLIP-Mediated Inhibition of Death Receptor Signaling. Journal of Biological Chemistry, 281, 2960-2968. http://dx.doi.org/10.1074/jbc.M511074200
|
[24]
|
Humke, E.W., Shriver, S.K., Starovasnik, M.A., Fairbrother, W.J. and Dixit, V.M. (2000) ICEBERG: A Novel Inhibitor of Interleukin-1β Generation. Cell, 103, 99-111. http://dx.doi.org/10.1016/S0092-8674(00)00108-2
|
[25]
|
Vaughn, D.E., Rodriguez, J., Lazebnik, Y. and Joshua-Tor, L. (1999) Crystal Structure of the Apaf-1 Caspase Recruitment Domain: An α-Helical Greek Key Fold for Apoptotic Signaling. Journal of Molecular Biology, 293, 439-447. http://dx.doi.org/10.1006/jmbi.1999.3177
|
[26]
|
Bae, J.Y. and Park, H.H. (2011) Crystal Structure of NALP3 Protein Pyrin Domain (PYD) and Its Implications in Inflammasome Assembly. Journal of Biological Chemistry, 286, 39528-39536. http://dx.doi.org/10.1074/jbc.M111.278812
|
[27]
|
Hiller, S., Kohl, A., Fiorito, F., Herrmann, T., Wider, G., Tschopp, J., et al. (2003) NMR Structure of the Apoptosis and Inflammation-Related NALP1 Pyrin Domain. Structure, 11, 1199-1205. http://dx.doi.org/10.1016/j.str.2003.08.009
|
[28]
|
Day, C.L., Dupont, C., Lackmann, M., Vaux, D.L. and Hinds, M.G. (1999) Solution Structure and Mutagenesis of the Caspase Recruitment Domain (CARD) from Apaf-1. Cell Death & Differentiation, 6, 1125-1132. http://dx.doi.org/10.1038/sj.cdd.4400584
|
[29]
|
Chou, J.J., Matsuo, H., Duan, H. and Wagner, G. (1998) Solution Structure of the RAIDD CARD and Model for CARD/CARD Interaction in Caspase-2 and Caspase-9 Recruitment. Cell, 94, 171-180. http://dx.doi.org/10.1016/S0092-8674(00)81417-8
|
[30]
|
Qin, H., Srinivasula, S.M., Wu, G., Fernandes-Alnemri, T., Alnemri, E.S. and Shi, Y. (1999) Structural Basis of Procaspase-9 Recruitment by the Apoptotic Protease-Activating Factor 1. Nature, 399, 549-557. http://dx.doi.org/10.1038/21124
|
[31]
|
Kumar, S. (1999) Mechanisms Mediating Caspase Activation in Cell Death. Cell Death & Differentiation, 6, 1060-1066. http://dx.doi.org/10.1038/sj.cdd.4400600
|
[32]
|
Liepinsh, E., Barbals, R., Dahl, E., Sharipo, A., Staub, E. and Otting, G. (2003) The Death-Domain Fold of the ASC PYRIN Domain, Presenting a Basis for PYRIN/PYRIN Recognition. Journal of Molecular Biology, 332, 1155-1163. http://dx.doi.org/10.1016/j.jmb.2003.07.007
|
[33]
|
Nam, Y.J., Mani, K., Ashton, A.W., Peng, C.F., Krishnamurthy, B., Hayakawa, Y., et al. (2004) Inhibition of Both the Extrinsic and Intrinsic Death Pathways through Nonhomotypic Death-Fold Interactions. Molecular Cell, 15, 901-912. http://dx.doi.org/10.1016/j.molcel.2004.08.020
|
[34]
|
Dioletis, E., Dingley, A.J. and Driscoll, P.C. (2013) Structural and Functional Characterization of the Recombinant Death Domain from Death-Associated Protein Kinase. PLoS ONE, 8, e70095. http://dx.doi.org/10.1371/journal.pone.0070095
|
[35]
|
Ferrao, R. and Wu, H. (2012) Helical Assembly in the Death Domain (DD) Superfamily. Current Opinion in Structural Biology, 22, 241-247. http://dx.doi.org/10.1016/j.sbi.2012.02.006
|
[36]
|
Kay, W.H.T, Darwiche, R., Irawaty, W., Chong, M.M.W., Pennington, H.L. and Thomas, H.E. (2003) The Role of Cytokines as Effectors of Tissue Destruction in Autoimmunity Cytokines and Chemokines in Autoimmune Disease. Kluwer Academic/Plenum Publishers, Dordrecht, 73-86.
|
[37]
|
Banner, D.W., D’Arcy, A., Janes, W., Gentz, R., Schoenfeld, H.J., Broger, C., et al. (1993) Crystal Structure of the Soluble Human 55 kd TNF Receptor-Human TNF Beta Complex: Implications for TNF Receptor Activation. Cell, 73, 431-445. http://dx.doi.org/10.1016/0092-8674(93)90132-A
|
[38]
|
Kischkel, F.C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P.H., et al. (1995) Cytotoxicity Dependent APO-1 (Fas/CD95)-Associated Proteins form a Death-Inducing Signaling Complex (DISC) with the Receptor. The EMBO Journal, 14, 5579-5588.
|
[39]
|
Salvesen, G.S. (2002) Caspases and Apoptosis. Essays in Biochemistry, 38, 9-19.
|
[40]
|
Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J.L., Mattmann, C., et al. (1998) Identification of CARDIAK, a RIP-Like Kinase That Associates with Caspase-1. Current Biology, 8, 885-888. http://dx.doi.org/10.1016/S0960-9822(07)00352-1
|
[41]
|
Druilhe, A., Srinivasula, S.M., Razmara, M., Ahmad, M. and Alnemri, E.S. (2001) Regulation of IL-1β Generation by Pseudo-ICE and ICEBERG, Two Dominant Negative Caspase Recruitment Domain Proteins. Cell Death & Differentiation, 8, 649-657. http://dx.doi.org/10.1038/sj.cdd.4400881
|
[42]
|
Zou, H., Henzel, W.J., Liu, X., Lutschg, A. and Wang, X. (1997) Apaf-1, a Human Protein Homologous to C. Elegans CED-4, Participates in Cytochrome c-Dependent Activation of Caspase-3. Cell, 90, 405-413. http://dx.doi.org/10.1016/S0092-8674(00)80501-2
|
[43]
|
O’Neill, L.A., Dunne, A., Edjeback, M., Gray, P., Jefferies, C. and Wietek, C. (2003) Mal and MyD88: Adapter Proteins Involved in Signal Transduction by Toll-Like Receptors. Innate Immunity, 9, 55-59. http://dx.doi.org/10.1177/09680519030090010701
|
[44]
|
Jadidi-Niaragh, F. and Mirshafiey, A. (2010) Histamine and Histamine Receptors in Pathogenesis and Treatment of Multiple Sclerosis. Neuropharmacology, 59, 180-189. http://dx.doi.org/10.1016/j.neuropharm.2010.05.005
|
[45]
|
Nicot, A. (2009) Gender and Sex Hormones in Multiple Sclerosis Pathology and Therapy. Frontiers in Bioscience, 14, 4477-4515. http://dx.doi.org/10.2741/3543
|
[46]
|
Neumann, H., Medana, I.M., Bauer, J. and Lassmann, H. (2002) Cytotoxic T Lymphocytes in Autoimmune and Degenerative CNS Diseases. Trends in Neurosciences, 25, 313-319. http://dx.doi.org/10.1016/S0166-2236(02)02154-9
|
[47]
|
Kasper, L.H. and Shoemaker, J. (2010) Multiple Sclerosis Immunology: The Healthy Immune System vs the MS Immune System. Neurology, 74, 2-8. http://dx.doi.org/10.1212/WNL.0b013e3181c97c8f
|
[48]
|
Friese, M.A. and Fugger, L. (2009) Pathogenic CD8+ T Cells in Multiple Sclerosis. Annals of Neurology, 66, 132-141. http://dx.doi.org/10.1002/ana.21744
|
[49]
|
Bettelli, E., Oukka, M. and Kuchroo, V.K. (2007) TH-17 Cells in the Circle of Immunity and Autoimmunity. Nature Immunology, 8, 345-350. http://dx.doi.org/10.1038/ni0407-345
|
[50]
|
Batoulis, H., Addicks, K. and Kuerten, S. (2010) Emerging Concepts in Autoimmune Encephalomyelitis beyond the CD4/TH1 Paradigm. Annals of Anatomy—Anatomischer Anzeiger, 192, 179-193. http://dx.doi.org/10.1016/j.aanat.2010.06.006
|
[51]
|
Huang, W.X., Huang, M.P., Gomes, M.A. and Hillert, J. (2000) Apoptosis Mediators FasL and TRAIL Are Upregulated in Peripheral Blood Mononuclear Cells in MS. Neurology, 55, 928-934. http://dx.doi.org/10.1212/WNL.55.7.928
|
[52]
|
Su-Yin, L. and Constantinescu, C.S. (2010) TNF-α: A Paradigm of Paradox and Complexity in Multiple Sclerosis and its Animal Models. The Open Autoimmunity Journal, 2, 160-170. http://dx.doi.org/10.2174/1876894601002040160
|
[53]
|
Korn, T., Magnus, T. and Jung, S. (2005) Autoantigen Specific T Cells Inhibit Glutamate Uptake in Astrocytes by Decreasing Expression of Astrocytic Glutamate Transporter GLAST: A Mechanism Mediated by Tumor Necrosis Factor-Alpha. The FASEB Journal, 19, 1878-1880.
|
[54]
|
Jurewicz, A., Matysiak, M., Tybor, K., Kilianek, L., Raine, C.S. and Selmaj, K. (2005) Tumor Necrosis Factor-Induced Death of Adult Human Oligodendrocytes Is Mediated by Apoptosis Inducing Factor. Brain, 128, 2675-2688. http://dx.doi.org/10.1093/brain/awh627
|
[55]
|
Pouly, S., Becher, B., Blain, M. and Antel, J.P. (2000) Interferon-Gamma Modulates Human Oligodendrocyte Susceptibility to Fas-Mediated Apoptosis. Journal of Neuropathology & Experimental Neurology, 59, 280-286.
|
[56]
|
Aktas, O., Prozorovski, T. and Zipp, F. (2006) Death Ligands and Autoimmune Demyelination. Neuroscientist, 12, 305-316. http://dx.doi.org/10.1177/1073858405285208
|
[57]
|
Sun, J., Hilliard, B., Xu, L. and Chen, Y.H. (2005) Essential Roles of the Fas-Associated Death Domain in Autoimmune Encephalomyelitis. The Journal of Immunology, 175, 4783-4788. http://dx.doi.org/10.4049/jimmunol.175.7.4783
|
[58]
|
Schneider, P., Bodmer, J.L, Thome, M., Hofmann, K., Holler, N. and Tschopp, J. (1997) Characterization of Two Receptors for TRAIL. FEBS Letters, 416, 329-334. http://dx.doi.org/10.1016/S0014-5793(97)01231-3
|
[59]
|
Dorr, J., Bechmann, I., Waiczies, S., Aktas, O., Walczak, H., Krammer, P.H., et al. (2002) Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand but Presence of Its Receptors in the Human Brain. Journal of Neuroscience, 22, RC209 1 of 5.
|
[60]
|
Matysiak, M., Jurewicz, A., Jaskolski, D. and Selmaj, K. (2002) TRAIL Induces Death of Human Oligodendrocytes Isolated from Adult Brain. Brain, 125, 2469-2480. http://dx.doi.org/10.1093/brain/awf254
|
[61]
|
Panitch, H.S., Hirsch, R.L., Schindler, J. and Johnson, K.P. (1987) Treatment of Multiple Sclerosis with Gamma Interferon: Exacerbations Associated with Activation of the Immune System. Neurology, 37, 1097-1102. http://dx.doi.org/10.1212/WNL.37.7.1097
|
[62]
|
Wosik, K., Antel, J., Kuhlmann, T., Bruck, W., Massie, B. and Nalbantoglu, J. (2003) Oligodendrocyte Injury in Multiple Sclerosis: A Role for p53. Journal of Neurochemistry, 85, 635-644. http://dx.doi.org/10.1046/j.1471-4159.2003.01674.x
|
[63]
|
Huang, Y., Erdmann, N., Peng, H., Zhao, Y. and Zheng, J. (2005) The Role of TNF Related Apoptosis-Inducing Ligand in Neurodegenerative Diseases. Cellular Molecular Immunology, 2, 113-122.
|
[64]
|
Hisahara, S., Araki, T., Sugiyama, F., Yagami, K., Suzuki, M., Abe, K., et al. (2000) Targeted Expression of Baculovirus p35 Caspase Inhibitor in Oligodendrocytes Protects Mice against Autoimmune Mediated Demyelination. The EMBO Journal, 19, 341-348. http://dx.doi.org/10.1093/emboj/19.3.341
|
[65]
|
Hovelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., et al. (2005) Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis. Journal of Immunology, 175, 5875-5884. http://dx.doi.org/10.4049/jimmunol.175.9.5875
|
[66]
|
van Loo, G., De Lorenzi, R., Schmidt, H., Huth, M., Mildner, A., Schmidt-Supprian, M., et al. (2006) Inhibition of Transcription Factor NF-kB in the Central Nervous System Ameliorates Autoimmune Encephalomyelitis in Mice. Nature Immunology, 7, 954-961. http://dx.doi.org/10.1038/ni1372
|
[67]
|
Stancovski, I. and Baltimore, D. (1997) NF-kB Activation: The IkB Kinase Revealed? Cell, 91, 299-302. http://dx.doi.org/10.1016/S0092-8674(00)80413-4
|
[68]
|
Liu, Z.G., Hsu, H., Goeddel, D.V. and Karin, M. (1996) Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-kB Activation Prevents Cell Death. Cel1, 87, 565-576. http://dx.doi.org/10.1016/S0092-8674(00)81375-6
|
[69]
|
Rai, N.K., Tripathi, K., Sharma, D. and Shukla, V.K. (2005) Apoptosis: A Basic Physiologic Process in Wound Healing. International Journal of Lower Extremity Wounds, 4, 138-144. http://dx.doi.org/10.1177/1534734605280018
|
[70]
|
Martinon, F. and Tschopp, J. (2004) Inflammatory Caspases: Linking an Intracellular Innate Immune System to Autoinflammatory Diseases. Cell, 117, 561-574. http://dx.doi.org/10.1016/j.cell.2004.05.004
|
[71]
|
Sutton, C., Brereton, C., Keogh, B., Mills, K.H.G. and Lavelle, E.C. (2006) A Crucial Role for Interleukin (IL)-1 in the Induction of IL-17-Producing T Cells That Mediate Autoimmune Encephalomyelitis. Journal of Experimental Medicine, 203, 1685-1691. http://dx.doi.org/10.1084/jem.20060285
|
[72]
|
Ferrari, C.C., Depino, A.M., Prada, F., Muraro, N. and Campbell, S. (2004) Reversible Demyelination, Blood-Brain Barrier Breakdown, and Pronounced Neutrophil Recruitment Induced by Chronic IL-1 Expression in the Brain. American Journal of Pathology, 165, 1827-1837. http://dx.doi.org/10.1016/S0002-9440(10)63438-4
|
[73]
|
Hisahara, S., Yuan, J., Momoi, T., Okano, I.H. and Miura, M. (2001) Caspase-11 Mediates Oligodendrocyte Cell Death and Pathogenesis of Autoimmune-Mediated Demyelination. Journal of Experimental Medicine, 193, 111-122. http://dx.doi.org/10.1084/jem.193.1.111
|
[74]
|
D’Souza, S.D., Bonetti, B., Balasingam, V., Cashman, N.R., Barker, P.A., Troutt, A.B., et al. (1996) Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death. Journal of Experimental Medicine, 184, 2361-2370. http://dx.doi.org/10.1084/jem.184.6.2361
|
[75]
|
Li, W.Y., Maeda, Y., Ming, X., Cook, S., Chapin, J., Husar, W. and Dowling, P. (2002) Apoptotic Death Following Fas Activation in Human Oligodendrocyte Hybrid Cultures. Journal of Neuroscience Research, 69, 189-196. http://dx.doi.org/10.1002/jnr.10285
|
[76]
|
Lassus, P., Opitz-Araya, X. and Lazebnik, Y. (2002) Requirement for Caspase-2 in Stress-Induced Apoptosis before Mitochondrial Permeabilization. Science, 297, 1352-1354. http://dx.doi.org/10.1126/science.1074721
|